Physician profile
Jose Gonzalez
NPI 1073601852
$3,382.08
in general payments reported to CMS, 2019-2025
20 companies · $28.01 in 2025
The $28.01 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $614 · 2021: $459 · 2022: $950 · 2023: $322 · 2024: $229 · 2025: $28.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,740.89 | 2019-2025 | Gallant, Assurity |
| Baxter Healthcare | $385.16 | 2022 | |
| Janssen Pharmaceuticals, INC | $244.31 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $190.77 | 2019-2024 | Wainua |
| Novartis Pharmaceuticals Corporation | $170.54 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $130.04 | 2022-2023 | Opsumit |
| Amgen INC. | $87.03 | 2022-2024 | Repatha |
| Tactile Systems Technology INC | $79.48 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $53.89 | 2019 | |
| Bardy Diagnostics, INC. | $45.00 | 2021-2022 | |
| Boston Scientific Corporation | $42.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.73 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $36.79 | 2019-2022 | |
| Medtronic, INC. | $35.55 | 2021 | |
| Edwards Lifesciences Corporation | $25.81 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $20.87 | 2022 | |
| Mylan Specialty L.P. | $17.48 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.67 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.56 | 2019 | |
| Philips North America LLC | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.